Despite a recent set of patent expirations in most major markets, Eli Lilly and Company has reported positive

The ever-evolving healthcare industry means that players must adapt to a systems-orientated approach in order to protect revenues

A slow start to sales of Bristol-Myers Squibb’s heart drug and fallen sales profits have led to a

GlaxoSmithKline has reported a second-quarter core EPS growth of 4% on sales earnings of 2%. However, the net

The UK Joint Committee on Vaccination and Immunisation (JCVI) has decided not to recommend Novartis’ Bexsero for inclusion

The two major pharma representative corporations in Europe and the US have strengthened their long-standing commitment to public

Colorado-based Array BioPharma has announced positive phase 2 clinical trial results of its asthma treatment ARRY-502, which is

Global drugmaker GlaxoSmithKline has suspended a deal to spend over $1 billion increasing its stakes in its consumer

Global pharma company, Boehringer Ingelheim, has announced the first recipients of the European Foundation for the Study of